|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cookson MS, Herr HW, Zhang ZF, et al: The
treated natural history of high risk superficial bladder cancer:
15-year outcome. J Urol. 158:62–67. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng L, Cheville JC, Neumann RM, et al:
Survival of patients with carcinoma in situ of the urinary bladder.
Cancer. 85:2469–2474. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitra AP, Datar RH and Cote RJ: Molecular
pathways in invasive bladder cancer: new insights into mechanisms,
progression and target identification. J Clin Oncol. 24:5552–5564.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nishiyama H, Watanabe J and Ogawa O: p53
and chemosensitivity in bladder cancer. Int J Clin Oncol.
13:282–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu N, Wang L, Li X, et al: N-Myc
downstream-regulated gene 2 is involved in p53-mediated apoptosis.
Nucleic Acids Res. 36:5335–5349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lorentzen A, Vogel LK, Lewinsky RH, et al:
Expression of NDRG2 is down-regulated in high-risk adenomas and
colorectal carcinoma. BMC Cancer. 7:1922007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li R, Yu C, Jiang F, et al: Overexpression
of N-Myc downstream-regulated gene 2 (NDRG2) regulates the
proliferation and invasion of bladder cancer cells in vitro and in
vivo. PLoS One. 8:e766892013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu X, Niu T, Hou W, et al: Microarray
profiling of HepG2 cells ectopically expressing NDRG2. Gene.
503:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng J, Li Y, Yang J, et al: NDRG2
inhibits hepatocellular carcinoma adhesion, migration and invasion
by regulating CD24 expression. BMC Cancer. 251:1–9. 2011.
|
|
12
|
Ma JJ, Liao CG, Jiang X, et al: NDRG2
suppresses the proliferation of clear cell renal cell carcinoma
cell A-498. J Exp Clin Cancer Res. 29:1032010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
14
|
Choi W, Czerniak B, Ochoa A, Su X,
Siefker-Radtke A, Dinney C and McConkey DJ: Intrinsic basal and
luminal subtypes of muscle-invasive bladder cancer. Nat Rev Urol.
11:400–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hummerich L, Müller R, Hess J, et al:
Identification of novel tumour-associated genes differentially
expressed in the process of squamous cell cancer development.
Oncogene. 25:111–121. 2006.
|
|
16
|
Liu N, Wang L, Liu X, et al: Promoter
methylation, mutation and genomic deletion are involved in the
decreased NDRG2 expression levels in several cancer cell lines.
Biochem Biophys Res Co. 358:164–169. 2007. View Article : Google Scholar
|
|
17
|
Lee DC, Kang YK, Kim WH, et al: Functional
and clinical evidence for NDRG2 as a candidate suppressor of liver
cancer metastasis. Cancer Res. 68:4210–4220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi SC, Yoon SR, Park YP, et al:
Expression of NDRG2 is related to tumor progression and survival of
gastric cancer patients through Fas-mediated cell death. Exp Mol
Med. 39:705–714. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boulkroun S, Fay M, Zennaro MC, et al:
Characterization of rat NDRG2 (N-Myc downstream regulated gene 2),
a novel early mineralocorticoid-specific induced gene. J Biol Chem.
277:31506–31515. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Liu J, Li X, et al: The physical
and functional interaction of NDRG2 with MSP58 in cells. Biochem
Biophys Res Commun. 352:6–11. 2007. View Article : Google Scholar
|
|
21
|
Wang L, Liu N, Yao L, et al: NDRG2 is a
new HIF-1 target gene necessary for hypoxia-induced apoptosis in
A549 cells. Cell Physiol Biochem. 21:239–250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cairns RA, Harris IS and Mark TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ward PS and Thompson CB: Metabolic
reprogramming: a cancer hallmark even warburg did not anticipate.
Cancer Cell. 21:297–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dang CV: Links between metabolism and
cancer. Genes Dev. 26:877–890. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park Y, Shon SK, Kim A, et al: SOCS1
induced by NDRG2 expression negatively regulates STAT3 activation
in breast cancer cells. Biochem Biophys Res Co. 363:361–367. 2007.
View Article : Google Scholar
|
|
26
|
Yao L, Zhang J and Liu X: NDRG2: a
Myc-repressed gene involved in cancer and cell stress. Acta Biochim
Biophys Sin (Shanghai). 40:625–635. 2008. View Article : Google Scholar
|
|
27
|
Kim YJ, Yoon SY, Kim JT, et al: NDRG2
suppresses cell proliferation through down-regulation of AP-1
activity in human colon carcinoma cells. Int J Cancer. 124:7–15.
2009. View Article : Google Scholar
|
|
28
|
Li T, Hu J, He GH, et al: Up-regulation of
NDRG2 through nuclear factor-kappa B is required for leydig cell
apoptosis in both human and murine infertile testes. Biochim
Biophys Acta. 1822:301–313. 2012. View Article : Google Scholar
|
